Overview of diagnosis, stage-based treatments, side effects and follow-up to help patients with cancer understand care choices and expectations. Oropharyngeal cancer develops in the oropharynx, the ...

Learn what you need to know about early-stage prostate cancer, from risk factors to treatment options and how to tackle their side effects. Prostate cancer: 1 in 8 men in the United States will be ...

The trial is part of a larger trend towards targeted chemotherapies, Santin says, many of which may come onto the market in the next few decades.

Keaton Herzer tells PEOPLE a newer targeted therapy unexpectedly shrank his tumors enough to qualify for a liver transplant ...

Prostate cancer is one of the most common cancers in the world. While many prostate cancers grow slowly and remain localized, other types are aggressive and spread quickly. That's why Dr. Carlos ...

Hear how cancer patients can preserve their fertility, with expert insights and inspiring stories from survivors and new parents. While cancer treatments can be lifesaving, they can also impact the ...

A comprehensive review of treatment options for patients with metastatic hormone-sensitive prostate cancer. Alicia Morgans, M.D., MPH: Metastatic hormone-sensitive prostate cancer is a particular type ...

The hospital now offers Pluvicto to battle advanced prostate cancer, the Thor device to prevent mouth sores during chemotherapy and a new kind of cooling cap therapy to help patients keep their hair ...

Prostate cancer is the most commonly diagnosed cancer in the UK, with more than 63,000 new cases each year. Yet for many men, understanding their treatment options remains far from straightforward ...

Head and neck cancer is the sixth most common cancer worldwide, and it affects around 12,800 people in the UK each year.

Vulvar cancer is a rare type of cancer that affects your vulva. Several options, such as topical medication, surgery, and chemotherapy, are available to treat cancerous and precancerous cells near ...

Local hospitals are bringing FDA-approved Bispecific T-cell Engager therapy to the region. Providers claim it could extend and improve blood cancer patients' quality of life. The hematology and ...